Status:
NOT_YET_RECRUITING
Health Chat for Empowerment-based Lifestyle Planning for Cardiometabolic Multimorbidity
Lead Sponsor:
The University of Hong Kong
Conditions:
Cardiometabolic Diseases
Multimorbidity
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The goal of this study is to: 1. assess the feasibility of the health chat for empowerment-based lifestyle planning for cardiometabolic multimorbidity (HcELP\_CMM); 2. examine the immediate effects o...
Detailed Description
This study has two parts. Part 1 is a sequential mixed-method pilot study consisted of a single-blind, parallel-group, two-arm randomized controlled trial followed by a qualitative descriptive study. ...
Eligibility Criteria
Inclusion
- Adults aged 18 years or above；
- Diagnosed with cardiometabolic multimorbidity (CMM) by doctors, which was defined as co-existing with two or more cardiometabolic diseases, including primary hypertension, primary type 2 diabetes, stroke, and heart diseases (eg. ischemic heart disease, arrhythmia, heart valve diseases, and other heart diseases);
- Possessed a digital device installed with WeChat, as well as with an internet connection.
Exclusion
- Contraindications to exercise according to American College of Sports Medicine (ACSM), such as severe musculoskeletal disorders, severe cardiovascular diseases, or spinal nerve injury;
- Diagnosis of psychiatric disease;
- Has impaired cognitive function as indicated by an Abbreviated Mental Test Score (AMTS) ≤6;
- Has impaired sensory or communication function which hider them participation in this program, such as hearing loss, vision loss, and unable to speak Mandarin;
- Unable to sign the informed consent form.
Key Trial Info
Start Date :
September 10 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 5 2027
Estimated Enrollment :
240 Patients enrolled
Trial Details
Trial ID
NCT07158697
Start Date
September 10 2025
End Date
February 5 2027
Last Update
September 8 2025
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Gusu District Feng Men Street Community Health Service Center
Suzhou, Jiangsu, China, 215000
2
Gusu District Jinchang Street Bailian Community Health Service Center
Suzhou, Jiangsu, China, 215000
3
Gusu District Shuang Ta Street Jinfan Community Health Service Center
Suzhou, Jiangsu, China, 215000